Annovis Bio Inc (ANVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 1,910 | 1,604 | 2,544 | 583 | 870 |
| Operating Income | -1,910 | -1,604 | -2,544 | -583 | -870 |
| Other Income | 205 | 597 | 234 | 142 | 669 |
| Pre-tax Income | -1,705 | -1,006 | -2,310 | -442 | -201 |
| Net Income Continuous | -1,705 | -1,006 | -2,310 | -442 | -201 |
| Net Income | $-1,705 | $-1,006 | $-2,310 | $-442 | $-201 |
| EPS Basic Total Ops | -0.28 | -0.15 | -0.34 | -0.10 | -0.71 |
| EPS Basic Continuous Ops | -0.29 | -0.15 | -0.34 | -0.10 | -0.71 |
| EPS Diluted Total Ops | -0.28 | -0.15 | -0.34 | -0.10 | -0.71 |
| EPS Diluted Continuous Ops | -0.29 | -0.15 | -0.34 | -0.10 | -0.71 |
| EBITDA(a) | $-1,910 | $-1,604 | $-2,544 | $-583 | $-869 |